Onconova Therapeutics Reports Full Year 2020 Financial Results, Provides Business Update
Conference call begins at 4:30 p.m. Eastern time todayNEWTOWN, Pa., March 11, 2021 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ:...
Reports
The ExOne Company Reports Fourth Quarter 2020 Results | Business & Finance
NORTH HUNTINGDON, Pa.--(BUSINESS WIRE)--Mar 11, 2021--The ExOne Company (Nasdaq: XONE) (“ExOne” or the “Company”), the global leader in industrial sand...
Potbelly Corporation Reports Results for Fourth Fiscal Quarter and Full Year 2020
Fourth quarter same-store sales resilient and improved 130 basis points sequentially to (19.7%)Continued to advance new strategic focus on “Traffic-Driven...
DBV Technologies Reports Full-Year 2020 Financial Results and Recent Business Developments
Montrouge, France, March 11, 2021DBV Technologies Reports Full-Year 2020 Financial Results and Recent Business Developments DBV Technologies S.A. (Euronext: DBV...
Selecta Biosciences Reports Recent Business Highlights and Fourth Quarter and Full Year 2020 Financial Results
- First-in-human dose-escalation study to evaluate ability of ImmTOR™ to mitigate immunogenicity of AAV capsid initiated with initial data expected...
Nuvation Bio Reports Full Year 2020 Financial Results and Provides Business Update
Closed business combination with Panacea, yielding new public listing and strong cash position of approximately $830 millionPatient enrollment ongoing in...
AutoWeb Reports Fourth Quarter and Full Year 2020 Results
- Continued Focus on Effective Traffic Acquisition and Operational Efficiencies Drive Highest Level of Q4 Gross Profit and Margin Since...
Assertio Reports Fourth Quarter and Full Year 2020 Financial Results
Full Year Net Product Sales of $93.5 Million; Full Year Pro-Forma Revenue of $119.2 Million in Line with GuidancePost Year-end...
22nd Century Group Reports Business Highlights and Financial Results for the Fourth Quarter and Full-Year 2020
Key Business and Financial Highlights22nd Century has a tremendous global commercial opportunity in the more than $800 billion markets across...
Aldeyra Therapeutics Reports Full-Year 2020 Financial Results and Recent Business Highlights
− Enrollment Completed in Phase 3 INVIGORATE Trial, with Top-Line Results Expected in the First Half of 2021− Top-Line Results...
TFF Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial and Business Results
Reports positive Phase 1 study results for Voriconazole Inhalation Powder and Tacrolimus Inhalation PowderAwarded subcontract license by U.S. government agency...
Aquestive Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update
Libervant™ (diazepam) Buccal Film New Drug Application (NDA) resubmission expected end of second quarter 2021Epinephrine program and development strategy to...
Stoke Therapeutics Reports Full Year 2020 Financial Results and Provides Business Updates
– First patient dosed in the multiple ascending dose portion of Phase 1/2a MONARCH study of STK-001 in Dravet syndrome...
Inari Medical Reports Fourth Quarter and Full Year 2020 Financial Results
IRVINE, Calif., March 09, 2021 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”) a commercial-stage medical device company focused...
Oak Street Health Reports Fourth Quarter 2020 Financial Results | Business & Finance
CHICAGO--(BUSINESS WIRE)--Mar 9, 2021--Oak Street Health, Inc. (NYSE: OSH) (the “Company”), a network of value-based, primary care centers for adults...
Marinus Pharmaceuticals Provides Business Update and Reports Fourth Quarter 2020 Financial Results
PCDH19 related epilepsy (PCDH19-RE) Phase 2 Violet Study Proof-of-Concept Trial (n=21) shows a median 61.5% reduction in seizure frequency for...
ERYTECH Provides Business Update and Reports Financial Results for the Full Year 2020
ERYTECH Provides Business Update and Reports Financial Results for the Full Year 2020Conference call and webcast on Tuesday, March 9,...
NextCure Provides Business Update and Reports Fourth Quarter and Full Year 2020 Financial Results
BELTSVILLE, Md., March 04, 2021 (GLOBE NEWSWIRE) -- NextCure, Inc. (Nasdaq: NXTC), a clinical-stage biopharmaceutical company committed to discovering and...
